Malik YA. Covid-19 variants: impact on transmissibility and virulence. Malays J Pathol. 2022;44(3):387–96.
Vassallo M, Manni S, Klotz C, Fabre R, Pini P, Blanchouin E et al. Patients admitted for variant alpha COVID-19 have poorer outcomes than those infected with the Old strain. J Clin Med. 2021;10(16).
Blanca D, Nicolosi S, Bandera A, Blasi F, Mantero M, Hu C, et al. Comparison between the first and second COVID-19 waves in Internal Medicine wards in Milan, Italy: a retrospective observational study. Intern Emerg Med. 2022;17(8):2219–28.
Bociąga-Jasik M, Wojciechowska W, Terlecki M, Wizner B, Rajzer M, Garlicki A et al. Comparison between COVID–19 outcomes in the first 3 waves of the pandemic: a reference hospital report. Pol Arch Intern Med. 2022;132(10).
Buttenschøn HN, Lynggaard V, Sandbøl SG, Glassou EN, Haagerup A. Comparison of the clinical presentation across two waves of COVID-19: a retrospective cohort study. BMC Infect Dis. 2022;22(1):423.
Meschiari M, Cozzi-Lepri A, Tonelli R, Bacca E, Menozzi M, Franceschini E, et al. First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy. BMJ Open. 2022;12(1):e054069.
Oladunjoye O, Gallagher M, Wasser T, Oladunjoye A, Paladugu S, Donato A. Mortality due to COVID-19 infection: a comparison of first and second waves. J Community Hosp Intern Med Perspect. 2021;11(6):747–52.
Slim MA, Appelman B, Peters-Sengers H, Dongelmans DA, de Keizer NF, Schade RP, et al. Real-world evidence of the effects of Novel treatments for COVID-19 on mortality: a nationwide comparative cohort study of hospitalized patients in the First, Second, Third, and fourth waves in the Netherlands. Open Forum Infect Dis. 2022;9(12):ofac632.
Booth A, Reed AB, Ponzo S, Yassaee A, Aral M, Plans D, et al. Population risk factors for severe disease and mortality in COVID-19: a global systematic review and meta-analysis. PLoS ONE. 2021;16(3):e0247461.
Li J, Huang DQ, Zou B, Yang H, Hui WZ, Rui F, et al. Epidemiology of COVID-19: a systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes. J Med Virol. 2021;93(3):1449–58.
Tian W, Jiang W, Yao J, Nicholson CJ, Li RH, Sigurslid HH, et al. Predictors of mortality in hospitalized COVID-19 patients: a systematic review and meta-analysis. J Med Virol. 2020;92(10):1875–83.
Malik P, Patel U, Mehta D, Patel N, Kelkar R, Akrmah M, et al. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis. BMJ Evid Based Med. 2021;26(3):107–8.
Alshaikh FS, Godman B, Sindi ON, Seaton RA, Kurdi A. Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: a systematic review and meta-analysis. PLoS ONE. 2022;17(8):e0272375.
Calderon M, Gysin G, Gujjar A, McMaster A, King L, Comandé D, et al. Bacterial co-infection and antibiotic stewardship in patients with COVID-19: a systematic review and meta-analysis. BMC Infect Dis. 2023;23(1):14.
Garcia-Vidal C, Sanjuan G, Moreno-García E, Puerta-Alcalde P, Garcia-Pouton N, Chumbita M, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2021;27(1):83–8.
Hughes S, Troise O, Donaldson H, Mughal N, Moore LSP. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clin Microbiol Infect. 2020;26(10):1395–9.
Karami Z, Knoop BT, Dofferhoff ASM, Blaauw MJT, Janssen NA, van Apeldoorn M, et al. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in the Netherlands. Infect Dis (Lond). 2021;53(2):102–10.
Lardaro T, Wang AZ, Bucca A, Croft A, Glober N, Holt DB, et al. Characteristics of COVID-19 patients with bacterial coinfection admitted to the hospital from the emergency department in a large regional healthcare system. J Med Virol. 2021;93(5):2883–9.
Moolla MS, Reddy K, Fwemba I, Nyasulu PS, Taljaard JJ, Parker A, et al. Bacterial infection, antibiotic use and COVID-19: lessons from the intensive care unit. S Afr Med J. 2021;111(6):575–81.
Vaughn VM, Gandhi TN, Petty LA, Patel PK, Prescott HC, Malani AN, et al. Empiric antibacterial therapy and community-onset bacterial coinfection in patients hospitalized with Coronavirus Disease 2019 (COVID-19): a multi-hospital cohort study. Clin Infect Dis. 2021;72(10):e533–41.
Belgium, COVID-19 Epidemiological Situation.: Sciensano; 2021 https://epistat.wiv-isp.be/covid/covid-19.html.
COVID-19 – Gevalsdefinitie en testing: Sciensano. 2021 https://covid-19.sciensano.be/nl/covid-19-gevalsdefinitie-en-testing.
Faes C, Abrams S, Van Beckhoven D, Meyfroidt G, Vlieghe E, Hens N. Time between Symptom Onset, Hospitalisation and Recovery or Death: statistical analysis of Belgian COVID-19 patients. Int J Environ Res Public Health. 2020;17(20).
De Motqr L, Dockx Y, Vandromme M, De Pauw R, Serrien B, Van Goethem JC N.K. Blot. COVID-19 Clinical hospital surveillance report. Brussels, Belgium: Sciensano, diseases EaphEoi; 2023 August, 2023.
Kartsonaki C, Baillie JK, Barrio NG, Baruch J, Beane A, Blumberg L et al. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19. Int J Epidemiol. 2023.
Taccone FS, Van Goethem N, De Pauw R, Wittebole X, Blot K, Van Oyen H, et al. The role of organizational characteristics on the outcome of COVID-19 patients admitted to the ICU in Belgium. Lancet Reg Health Eur. 2021;2:100019.
Tuty Kuswardhani RA, Henrina J, Pranata R, Anthonius Lim M, Lawrensia S, et al. Charlson comorbidity index and a composite of poor outcomes in COVID-19 patients: a systematic review and meta-analysis. Diabetes Metab Syndr. 2020 Nov-Dec;14(6):2103–9. https://doi.org/10.1016/j.dsx.2020.10.022. Epub 2020 Oct 28. PMID: 33161221; PMCID: PMC7598371.
Amado LA, Coelho WLDCNP, Alves ADR, Carneiro VCS, Moreira ODC, et al. Clinical Profile and Risk factors for severe COVID-19 in hospitalized patients from Rio De Janeiro, Brazil: comparison between the first and second pandemic waves. J Clin Med. 2023;12(7):2568. https://doi.org/10.3390/jcm12072568. PMID: 37048652; PMCID: PMC10094970.
Sadeghi F, Halaji M, Shirafkan H, Pournajaf A, Ghorbani H, et al. Characteristics, outcome, duration of hospitalization, and cycle threshold of patients with COVID-19 referred to four hospitals in Babol City: a multicenter retrospective observational study on the fourth, fifth, and sixth waves. BMC Infect Dis. 2024;24(1):55. https://doi.org/10.1186/s12879-023-08939-w. PMID: 38184533; PMCID: PMC10771668.